🚀 VC round data is live in beta, check it out!

MedApp Valuation Multiples

Discover revenue and EBITDA valuation multiples for MedApp and similar public comparables like Physitrack, EUDA Health, NextPlat, Welby and more.

MedApp Overview

About MedApp

MedApp SA develops mobile solutions for medicine. The company's products include Carna Life and Holo.


Founded

N/A

HQ

Poland

Employees

19

Website

medapp.pl

Financials (FY)

Revenue: $1M
EBITDA: $264K

EV

$16M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MedApp Financials

MedApp reported last fiscal year revenue of $1M and EBITDA of $264K.

In the same fiscal year, MedApp generated $356K in gross profit, $264K in EBITDA, and had net loss of ($598K).


MedApp P&L

In the most recent fiscal year, MedApp reported revenue of $1M and EBITDA of $264K.

MedApp expects next 12-month revenue of XXX and NTM EBITDA of XXX

See MedApp forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$1MXXXXXXXXX
Gross ProfitXXX$356KXXXXXXXXX
Gross MarginXXX33%XXXXXXXXX
EBITDAXXX$264KXXXXXXXXX
EBITDA MarginXXX25%XXXXXXXXX
EBIT MarginXXX(36%)XXXXXXXXX
Net ProfitXXX($598K)XXXXXXXXX
Net MarginXXX(56%)XXXXXXXXX
Net Debt$264KXXXXXXXXX

Financial data powered by Morningstar, Inc.

MedApp Stock Performance

MedApp has current market cap of $16M, and enterprise value of $16M.

Market Cap Evolution


MedApp's stock price is $0.06.

See MedApp trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$16M$16M11.6%XXXXXXXXX$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MedApp Valuation Multiples

MedApp trades at 14.9x EV/Revenue multiple, and 60.5x EV/EBITDA.

See valuation multiples for MedApp and 15K+ public comps

MedApp Financial Valuation Multiples

As of April 19, 2026, MedApp has market cap of $16M and EV of $16M.

Equity research analysts estimate MedApp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

MedApp has a P/E ratio of (26.2x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$16MXXX$16MXXXXXXXXX
EV (current)$16MXXX$16MXXXXXXXXX
EV/RevenueXXX14.9xXXXXXXXXX
EV/EBITDAXXX60.5xXXXXXXXXX
EV/EBITXXX(42.0x)XXXXXXXXX
EV/Gross ProfitXXX44.8xXXXXXXXXX
P/EXXX(26.2x)XXXXXXXXX
EV/FCFXXX117.0xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MedApp Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MedApp Margins & Growth Rates

MedApp's revenue in the last fiscal year declined by (47%).

MedApp's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

See operational valuation multiples for MedApp and other 15K+ public comps

MedApp Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(47%)XXXXXXXXX
EBITDA MarginXXX25%XXXXXXXXX
EBITDA GrowthXXX(84%)XXXXXXXXX
Revenue per EmployeeXXX$0.1MXXXXXXXXX
Opex per EmployeeXXX$0.0MXXXXXXXXX
S&M Expenses to RevenueXXX3%XXXXXXXXX
G&A Expenses to RevenueXXX59%XXXXXXXXX
Opex to RevenueXXX69%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

MedApp Public Comps

See public comps and valuation multiples for other Health Data & Analytics and Healthcare Software comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
MedAppXXXXXXXXXXXXXXXXXX
PhysitrackXXXXXXXXXXXXXXXXXX
EUDA HealthXXXXXXXXXXXXXXXXXX
NextPlatXXXXXXXXXXXXXXXXXX
WelbyXXXXXXXXXXXXXXXXXX
Bullfrog AIXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

MedApp M&A Activity

MedApp acquired XXX companies to date.

Last acquisition by MedApp was on XXXXXXXX, XXXXX. MedApp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by MedApp

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

MedApp Investment Activity

MedApp invested in XXX companies to date.

MedApp made its latest investment on XXXXXXXX, XXXXX. MedApp invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by MedApp

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MedApp

Where is MedApp headquartered?MedApp is headquartered in Poland.
How many employees does MedApp have?As of today, MedApp has over 19 employees.
Is MedApp publicly listed?Yes, MedApp is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of MedApp?MedApp trades under MDA ticker.
When did MedApp go public?MedApp went public in 2011.
Who are competitors of MedApp?MedApp main competitors are Physitrack, EUDA Health, NextPlat, Welby.
What is the current market cap of MedApp?MedApp's current market cap is $16M.
What is the current revenue of MedApp?MedApp's last fiscal year revenue is $1M.
What is the current EV/Revenue multiple of MedApp?Current revenue multiple of MedApp is 14.9x.
Is MedApp profitable?No, MedApp is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial